¡¾Öйú£¬£¬£¬£¬£¬£¬£¬ÉϺ£¡¿ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾¿­ÌØÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾½ñÈÕÐû²¼£¬£¬£¬£¬£¬£¬£¬¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾Ö£¨NMPA£©ÒÑÕýʽÅú×¼¹«Ë¾CD19°Ðµã×ÔÌåCAR-Tϸ°ûÖÎÁƲúÆ·°¢»ùÂØÈü×¢ÉäÒº£¨FKC876£©µÄÐÂÔö˳Ӧ֢ע²áÁÙ´²ÊÔÑéÉêÇë(IND)¡¾ÊÜÀíºÅCXSL2100098¡¿£¬£¬£¬£¬£¬£¬£¬ÓÃÓÚÖÎÁƶþÏß»òÒÔÉÏϵͳÐÔÖÎÁƺ󸴷¢»òÄÑÖÎÐÔ¶èÐÔ·Ç»ôÆæ½ðÁÜ°ÍÁö£¨r/r iNHL£©¡£¡£¡£¡£¡£¡£¡£¡£

ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾¿­ÌØCEO»Æº£ÏÈÉúÌåÏÖ£º¡°2021Äê3ÔÂ5ÈÕ£¬£¬£¬£¬£¬£¬£¬FDA¼ÓËÙÅú×¼ÁËYescarta £¨axicabtagene ciloleucel£©ÓÃÓÚÖÎÁƸ´·¢/ÄÑÖÎÐÔÂËÅÝÐÔÁÜ°ÍÁö³ÉÈË»¼Õߣ¬£¬£¬£¬£¬£¬£¬ÎÒÃǺÜÐË·Ü¿´µ½ÔÚÖйúFKC876£¨axicabtagene ciloleucel£©´ËÏîÐÂÔö˳Ӧ֢µÄINDÒ²»ñµÃÁËNMPAµÄÅú×¼£¬£¬£¬£¬£¬£¬£¬ÕâÒâζ×ÅÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾¿­ÌØCAR-Tϸ°ûÖÎÁƲúÆ·µÚ¶þ¸ö˳Ӧ֢½øÈëÁÙ´²½×¶Î¡£¡£¡£¡£¡£¡£¡£¡£ºÜÊÇллî¿Ïµ²¿·Ö¶ÔÁ¢ÒìÁÆ·¨µÄÃãÀøºÍÖ§³Ö£¬£¬£¬£¬£¬£¬£¬ÎÒÃǺÜÊÇÆÚ´ýЯÊÖÖйúµÄÁÙ´²×¨¼Ò¿ªÕ¹Ïà¹ØÊÔÑ飬£¬£¬£¬£¬£¬£¬Îª¸Ã²úÆ·ÐÂÔö˳Ӧ֢ÔÚÖйúµÄ×¢²áÉÏÊÐÌṩÖ÷ÒªÒÀ¾Ý£¬£¬£¬£¬£¬£¬£¬¾¡¿ìΪÖйú¸ü¶à·Ç»ôÆæ½ðÁÜ°ÍÁö»¼Õß´øÀ´ÐÂÉúµÄÏ£ÍûºÍʱ»ú¡£¡£¡£¡£¡£¡£¡£¡£¡±
¡±
¹ØÓÚ¶èÐÔ·Ç»ôÆæ½ðÁÜ°ÍÁö£¨iNHL£©
¶èÐÔ·Ç»ôÆæ½ðÁÜ°ÍÁö£¨iNHL£©ÊÇÁÙ´²Ï£Íû»ºÂýµ«Ëæ×Åʱ¼äÍÆÒÆ»á±äµÃ¸ü¾ßÇÖÏ®ÐԵĶñÐÔÖ×Áö¡£¡£¡£¡£¡£¡£¡£¡£ÂËÅÝÐÔÁÜ°ÍÁö£¨FL£©ºÍ±ßÑØÇøÁÜ°ÍÁö£¨MZL£©¶¼ÊÇÆä³£¼ûÑÇÐÍ¡£¡£¡£¡£¡£¡£¡£¡£FLÒ²ÊÇÈ«ÇòµÚ¶þ´ó³£¼ûµÄÁÜ°ÍÁöÀàÐÍ£¬£¬£¬£¬£¬£¬£¬Ô¼Õ¼È«ÇòNHLÈ·ÕﲡÀýµÄ22£¥¡£¡£¡£¡£¡£¡£¡£¡£MZLÊǵÚÈý´ó³£¼ûÁÜ°ÍÁö£¬£¬£¬£¬£¬£¬£¬Ô¼Õ¼ËùÓÐBϸ°ûNHLµÄ8£¥ÖÁ12£¥1¡£¡£¡£¡£¡£¡£¡£¡£ËäÈ»Ëæ׿²²¡ÖÎÀíµÄÇ°½ø£¬£¬£¬£¬£¬£¬£¬FL»¼Õߺã¾ÃÉúÑÄÂÊÓÐÁ˺ܴóÌá¸ß£¬£¬£¬£¬£¬£¬£¬µ«Ô¤ºóÈ´±£´æºÜ´ó²î±ð¡£¡£¡£¡£¡£¡£¡£¡£ÏÖÔÚ¹ØÓÚ¾­ÓɶþÏß¼°ÒÔÉÏÖÎÁƺ󸴷¢ºÍÄÑÖεÄFL»¼ÕßÉÐÎÞ±ê×¼ÖÎÁƼƻ®£¬£¬£¬£¬£¬£¬£¬¸´¾ÙÊÂÖεÄMZL»¼ÕßÖÎÁÆÑ¡ÔñÒ²ºÜÊÇÓÐÏÞ¡£¡£¡£¡£¡£¡£¡£¡£

? ¹ØÓÚFKC876?
FKC876ÊÇÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾¿­ÌØ2017ÄêÍ·´ÓÃÀ¹úKite£¨ÏéÈðµÂÆìϹ«Ë¾£©Òý½øYescarta (axicabtagene ciloleucel)ÊÖÒÕÔÚÖйú¾ÙÐй¤Òµ»¯µÄCAR-Tϸ°ûÖÎÁƲúÆ·¡£¡£¡£¡£¡£¡£¡£¡£ÆäÓÃÓÚÖÎÁƼÈÍù½ÓÊܶþÏß»òÒÔÉÏϵͳÐÔÖÎÁƺ󸴷¢»òÄÑÖÎÐÔ´óBϸ°ûÁÜ°ÍÁö³ÉÈË»¼Õߣ¨°üÀ¨ÃÖÂþÐÔ´óBϸ°ûÁÜ°ÍÁö·ÇÌØÖ¸ÐÍ¡¢Ô­·¢ÐÔ×ݸô´óBϸ°ûÁÜ°ÍÁö¡¢¸ß¼¶±ðBϸ°ûÁÜ°ÍÁöºÍÂËÅÝÁÜ°ÍÁöת»¯µÄÃÖÂþ´óBϸ°ûÁÜ°ÍÁö£©µÄÐÂÒ©ÉÏÊÐÉêÇëÒÑÓÚ2020Äê3Ô±»NMPAÄÉÈëÓÅÏÈÉóÆÀ¡£¡£¡£¡£¡£¡£¡£¡£

? ¹ØÓÚYescarta
YescartaÒÑÓÚ2017Äê10ÔÂ18ÈÕ»ñµÃÃÀ¹úFDAÅú×¼ÉÏÊУ¬£¬£¬£¬£¬£¬£¬ÓÃÓÚÖÎÁƸ´¾ÙÊÂÖÎÐÔ´óBϸ°ûÁÜ°ÍÁö³ÉÈË»¼Õߣ¬£¬£¬£¬£¬£¬£¬°üÀ¨ÃÖÂþÐÔ´óBϸ°ûÁÜ°ÍÁö£¨DLBCL£©·ÇÌØÖ¸ÐÍ¡¢Ô­·¢ÐÔ×ݸôBϸ°ûÁÜ°ÍÁö£¨PMBCL£©¡¢¸ß¼¶±ðBϸ°ûÁÜ°ÍÁöºÍÂËÅÝÁÜ°ÍÁöת»¯µÄDLBCL£¬£¬£¬£¬£¬£¬£¬ÊÇÃÀ¹úFDAÅú×¼µÄÊ׿îÕë¶ÔÌض¨·Ç»ôÆæ½ðÁÜ°ÍÁöµÄCAR-Tϸ°ûÒ©Îï¡£¡£¡£¡£¡£¡£¡£¡£

2020Äê3ÔÂ5ÈÕ£¬£¬£¬£¬£¬£¬£¬ÆäÓÃÓÚÖÎÁƸ´·¢/ÄÑÖÎÐÔÂËÅÝÐÔÁÜ°ÍÁö£¨FL£©³ÉÈË»¼ÕßµÄÀ©Õ¹Ë³Ó¦Ö¢ÉêÇë»ñµÃÃÀ¹úFDA¼ÓËÙÅú×¼£¬£¬£¬£¬£¬£¬£¬³ÉΪȫÇòÊ׸ö»ñÅúÉÏÊÐÓÃÓÚFLµÄCAR-Tϸ°ûÖÎÁƲúÆ·¡£¡£¡£¡£¡£¡£¡£¡£Æ¾Ö¤ZUMA-5µ¥±Û¡¢¿ª·Å±êÇ©¡¢¶àÖÐÐÄÊÔÑéЧ¹û£¬£¬£¬£¬£¬£¬£¬ÖÐλËæ·Ã17.5¸öÔ£¬£¬£¬£¬£¬£¬£¬ 92£¥µÄ¸´·¢/ÄÑÖÎÐÔ¶èÐÔNHL»¼Õߣ¨n=104£©¶ÔYescarta±¬·¢Ó¦´ð£¬£¬£¬£¬£¬£¬£¬76%µÖ´ïÍêÈ«»º½â£¬£¬£¬£¬£¬£¬£¬ÖÐλDOR¡¢PFS¼°OS¾ùδµÖ´ï£¬£¬£¬£¬£¬£¬£¬ÆäÖÐ64£¥µÄFL»¼ÕßÈÔ´¦ÓÚÒ»Á¬»º½â2¡£¡£¡£¡£¡£¡£¡£¡£

¹ØÓÚÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾¿­ÌØ
ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾¿­ÌØÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾ÎªÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾ÓëÃÀ¹úKite£¨ÏéÈðµÂ¿ÆѧÆìϹ«Ë¾£©µÄºÏÓªÆóÒµ£¬£¬£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚÖ×ÁöÃâÒßϸ°ûÖÎÁƲúÆ·µÄÑз¢ºÍ¹¤Òµ»¯¹æ·¶»¯Éú³¤£¬£¬£¬£¬£¬£¬£¬Ô츣Öйú»¼Õß¡£¡£¡£¡£¡£¡£¡£¡£¹«Ë¾×ܲ¿Î»ÓÚÉϺ£ÕŽ­¸ß¿Æ¼¼Ô°Çø£¬£¬£¬£¬£¬£¬£¬10000ƽ·½Ã×µÄCAR-T¹¤Òµ»¯Éú²ú»ùµØÒÑÔÚÕŽ­Á¢ÒìÒ©¹¤Òµ»ùµØ½¨³É²¢ÕýʽÆôÓᣡ£¡£¡£¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬£¬¹«Ë¾»¹ÓµÓÐ2000ƽÃ×µÄϸ°ûÖÎÁÆÑз¢ÖÐÐĺÍÁ¢ÒìÈ˲ÅÍŶӣ¬£¬£¬£¬£¬£¬£¬Í¨¹ý×ÔÖ÷Á¢ÒìºÍ¹ú¼ÊÏàÖú£¬£¬£¬£¬£¬£¬£¬×¨×¢ CAR-T/TCR-TÔçÆÚÑз¢ºÍÁÙ´²Ñ­Ö¤½×¶ÎµÄÏîÄ¿£¬£¬£¬£¬£¬£¬£¬´òÔì¿ÉÒ»Á¬µÄÁ¢ÒìÑз¢¹ÜÏß¡£¡£¡£¡£¡£¡£¡£¡£
ÓйØÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾¿­Ìظü¶àÐÅÏ¢£¬£¬£¬£¬£¬£¬£¬Çë»á¼ûwww.fosunkitebio.com

Êý¾ÝȪԴ£º
1. NCCN Guideline V1. 2020 B-cell Lymphomas

? ÉùÃ÷£º½ö¹©Ã½ÌåʹÓÃ?